Skip to content

Public FDA record

Z-0215-2022: Hemodialysis Delivery System, Software Version 2.x.

Recall record Z-0215-2022 for Baxter Healthcare Corporation. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0215-2022
Company in FDA record
Baxter Healthcare Corporation
FDA record creation date
Nov 11, 2021
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

If the operator initiates therapy with a saved prescription profile and makes a change to the prescription after a disposable filter change using the Same Patient button, the system may suggest values from the original prescription profile, rather than the current prescription.

Source facts

Action
An Urgent Medical Device Correction communication was sent to affected customers via U.S.P.S., first class mail, on 09/29/2021. Baxter advises the following: 1. Operators may continue to safely use the PrisMax System with software version 2.x until the system is upgraded to version 3.x. To ensure patient safety, operators must follow the Operator s Manual and confirm all prescription fields are accurate prior to starting treatment, or when making prescription changes during therapy. The instructions can be found in the PrisMax Operating Instructions section of the Operator s Manual. Additionally, follow the onscreen reminders to periodically check patient blood chemistry. The device should only be used by a trained operator per the instructions in the Operator s Manual. Please ensure that every operator of this device is made aware of this Urgent Medical Device Correction. 2. When the software upgrade becomes available, a local Baxter Service representative will contact your facility to determine the correction plan and schedule the upgrade for impacted devices. Your facility will be receiving this upgrade from Baxter at no charge. 3. If you received this communication directly from Baxter, acknowledge receipt of this letter by completing a reply form on our customer portal at https://BaxterFieldActionCustomerPortal.onprocess.com/. Log in to the portal using the account number listed at the top of the enclosed reply form instruction sheet. Acknowledging receipt of this notification will prevent you from receiving repeat notices. If you do not complete the acknowledgement, you will receive a phone call from OnProcess Technology on behalf of Baxter to confirm your receipt of this notification. 4. If you purchased this product from a distributor, please note that the Baxter reply form is not applicable. If a reply form is provided by your distributor or wholesaler, please return it to the supplier according to their instructions. 5. If you distribute this
Initiated
2021-09-29
Root cause
Software design
Distribution
Distributed nationwide to AL, AR, AZ, CA, CO, CT, FL, GA, HI, ID, IL, IN, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NH, NJ, NM, NV, NY, OH, OR, PA, SC,SD, TN, TX, UT, VA, WA, WI and internationally to Mexico, Brazil, Canada, Australia, Singapore, Hong Kong, Vietnam, Austria, Belgium, Denmark, Finland, Germany, Greece, Ireland, Israel, Italy, Luxemburg, Netherlands, Norway, Poland, Portugal, Saudi Arabia, Spain, Sweden, Switzerland, Turkey, and United Kingdom.
Recall number
Z-0215-2022
Recall status
Open, Classified
CDRH record ID
189349
FDA record created
2021-11-11
Recall event number
88695

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗